Scholar Rock
SRRK
41 hedge funds and large institutions have $308M invested in Scholar Rock in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
11% more funds holding
Funds holding: 37 → 41 (+4)
1.14% more ownership
Funds ownership: 51.92% → 53.06% (+1.1%)
8% less capital invested
Capital invested by funds: $334M → $308M (-$26.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$24.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.6M |
| 3 |
JP Morgan Chase
New York
|
+$2.13M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.04M |
| 5 |
Millennium Management
New York
|
+$882K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$20.2M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.74M |
| 3 |
AG
Artal Group
Luxembourg
|
-$2.26M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$591K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$386K |
SRRK Hedge Fund Activity: Q4 2018 in Review
41 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Scholar Rock (SRRK) for Q4 2018, worth a combined $308M — down 7.8% from $334M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new SRRK positions and 5 closed out — a net gain of 4 holders — while 16 added to existing stakes and 10 trimmed.
The largest buyer was BB Biotech, adding an estimated $24.7M. The largest seller was EcoR1 Capital, cutting an estimated $20.2M.
- 41 institutional investors held Scholar Rock (SRRK) as of Q4 2018, up from 37 in Q3 2018.
- Funds reported $308M of Scholar Rock stock for Q4 2018, down 7.8% quarter-over-quarter.
- 9 funds opened new Scholar Rock positions in Q4 2018 and 5 closed out, a net change of +4 holders.
- The largest Scholar Rock buyer in Q4 2018 was BB Biotech, an estimated $24.7M added.
- The largest Scholar Rock seller in Q4 2018 was EcoR1 Capital, an estimated $20.2M sold.
Based on aggregated 13F filings for Q4 2018.